Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Intellicheck Inc (IDN)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$2.01-3.83%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.02 → 0.02 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for IDN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Net income grows to at least $636K in Q1 2026 | Profit rises with operating income at $542K and net income at $636K in Q1 2026. | Intact | Net income falls below $500,000 in Q1 2026 | Net income: $663,000 FY2026-Q2; GAAP. Published target: >= $636,000. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 13, 2026663,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
IDN is a small-cap growth and profitability-improvement story, not yet a proven durable compounder. Its long-term thesis is intact, with robust earnings quality and stable management, but recent financial performance is neutral and overall risk is high.
The valuation evidence is mixed: IDN is described as cheap versus peers, while its measured premium versus peers is 0.59. The expectations gap is negative, suggesting expectations are not especially demanding, but confidence in that reading is only medium.
Near-term results show double-digit revenue growth and a shift from operating and net losses to positive income, while company momentum has improved. Still, an August earnings miss and recent peer misses leave some risk of weaker results or guidance; a guidance cut on the next call would be a meaningful negative.
Over the next few quarters, the thesis depends on revenue growth continuing and positive operating and net income being sustained. A Fed rate-cutting cycle or steadier results and guidance from large technology peers could improve the sector backdrop, while weaker guidance would challenge the business case.
For the next 1 to 3 years, IDN’s improving growth and profitability support an intact long-term thesis, but execution and high risk remain central. The valuation signals are mixed, so the case rests on continued operating progress rather than a clear expectations advantage. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Profit rises with operating income at $542K and net income at $636K in Q1 2026. |
| Intact |
| Operating income falls below $400,000 in Q1 2026 |
Operating income: $573,000 FY2026-Q2; GAAP. Published target: >= $542,000. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 13, 2026573,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: ““We remain focused on cost discipline, while continuing to fund the engineering behind our platform accuracy and availability, and the go-to-market investment required to grow our revenue from current and new customers,” said Adam Sragovicz, Chief Financial Officer of Intellicheck.” “Operating expenses for the three months ended March 31, 2026, which consist of selling, general and administrative expenses and research and development expenses decreased by 5.4% to $4,483,000 for the first quarter of 2026 compared to $4,740,000 for the same period of 2025.” Operating income was $0.542 million in 2026-Q1. Delivery assessment Nov 4, 2026 |
Revenue grows to at least $22.67M in 2026 | A primary condition in Intellicheck Inc's published investment case. The stated target is >= $22.67 million. | Intact | Revenue falls below $20.9 million in FY26 | Revenue: $5.941M FY2026-Q2; GAAP. Published target: >= $22.67 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 20265,941,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.17 → $0.02 · observed estimates
$0.03B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-07-25 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-07-26 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-07-27 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-07-28 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-07-29 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-07-30 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-07-31 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-01 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-02 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-03 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-04 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-05 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-06 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-07 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-08 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-09 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-10 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-12 | $0.23 | $26,220,000 | 2 / 2 |
| 2026-08-13 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-14 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-15 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-16 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-17 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-18 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-19 | $0.17 | $26,220,000 | 1 / 1 |
| 2026-08-20 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-21 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-22 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-23 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-24 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-25 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-26 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-27 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-28 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-29 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-30 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-08-31 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-01 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-02 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-03 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-04 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-05 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-06 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-07 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-08 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-09 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-10 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-11 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-12 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-13 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-14 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-15 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-16 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-17 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-18 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-19 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-20 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-21 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-22 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-23 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-24 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-25 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-26 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-27 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-28 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-29 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-09-30 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-01 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-02 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-03 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-04 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-05 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-06 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-07 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-08 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-09 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-10 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-11 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-12 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-13 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-14 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-15 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-16 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-17 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-18 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-19 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-20 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-21 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-22 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-23 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-24 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-25 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-26 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-27 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-28 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-29 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-30 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-10-31 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-11-01 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-11-02 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-11-03 | $0.02 | $21,045,000 | 1 / 1 |
| 2026-11-04 | $0.02 | $21,045,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.